0
0
0
ALS Placebo No More Act
10/28/2022, 1:46 AM
Congressional Summary of HR 5480
ALS Placebo No More Act
This bill requires the Food and Drug Administration and the National Institutes of Health to collaborate to provide all patients with ALS (amyotrophic lateral sclerosis, also referred to as Lou Gehrig's disease) with access to medicines in clinical trials.
Read the Full Bill
Current Status of Bill HR 5480
Bill HR 5480 is currently in the status of Bill Introduced since December 18, 2019. Bill HR 5480 was introduced during Congress 116 and was introduced to the House on December 18, 2019. Bill HR 5480's most recent activity was Referred to the Subcommittee on Health. as of December 19, 2019
Bipartisan Support of Bill HR 5480
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
3Democrat Cosponsors
0Republican Cosponsors
3Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 5480
Primary Policy Focus
HealthPotential Impact Areas
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Medical research
- Neurological disorders
Alternate Title(s) of Bill HR 5480
ALS Placebo No More Act
To ensure that ALS patients have access to treatment within clinical trials.
ALS Placebo No More Act
Comments
Sponsors and Cosponsors of HR 5480
Latest Bills
Palliative Care and Hospice Education and Training Act
Bill S 2287April 6, 2026
Downwinder Commemoration Act of 2025
Bill HR 4290April 6, 2026
EVEST Act
Bill HR 4114April 6, 2026
Every Veteran Housed Act
Bill HR 3869April 6, 2026
Right to Treat Act
Bill S 1830April 6, 2026
MAPS Act
Bill S 1784April 6, 2026
Chip Security Act
Bill HR 3447April 6, 2026
Words Matter Act of 2025
Bill HR 3420April 6, 2026
Conscience Protection Act of 2025
Bill S 1756April 6, 2026
ASSIST Act of 2025
Bill S 1726April 6, 2026